The RAD17 gene product of S. Pombe is an essential component of the checkpoint control pathway which responds to both DNA damage and disruption of replication. We have identi®ed a human cDNA that encodes a polypeptide which is structurally conserved with the S. Pombe Rad17 protein. The human gene, designated hRAD17, predicts an encoded protein of 590 amino acids and a molecular weight of 69 kD. Amino acid sequence alignment revealed that hRad17 has 28.3% and 52.5% similarity with the S. Pombe Rad17 protein, and 21.8% identity and 45.8% similarity to the budding yeast cell cycle checkpoint protein, Rad 24. When introduced into the S. Pombe rad17 mutant, hRAD17 was able to partially revert its hydroxyurea and ionizing radiation hypersensitivity, but not its UV hypersensitivity. Permanent overexpression of the hRAD17 gene in human ®brosarcoma cells resulted in p53 activation and a signi®cant reduction of S-and G2/ M-phase cells accompanied by an accumulation of the G1-phase population, suggesting that hRAD17 may have a role in cell cycle checkpoint control. Immunostaining of HT-1080 cells transiently transfected with a hRAD17 construct con®rmed the nuclear accumulation of p53, which mimics the induction caused by DNA damage. Using FISH analysis, we have mapped the hRAD17 locus to human chromosome 5q11.2.
Introduction
DNA damage checkpoints are signal transduction systems that link damage to DNA, or incomplete DNA synthesis, with the components of the cell cycle. Signals originating from damaged DNA activate checkpoint pathways and target the mitotic apparatus through a number of distinct mechanisms including: induction of cdk inhibitors, down-regulation of cyclin expression, and inhibition of cdk phosphorylation/ dephosphorylation required in normal cell cycle transition. Consequently, the cell cycle arrests at G1/ S, S, and G2/M stages depending upon where in the cell cycle the damage is sensed, thus minimizing proliferation of mutant cells and allowing damaged DNA to be corrected by repair pathways and interrupted replication to be completed (Elledge, 1996; Nurse, 1997; Paulovich et al., 1997) .
DNA damage checkpoints in lower eukaryotes have been extensively investigated. In the budding yeast S. Cerevisiae, scRAD9, scRAD17, scRAD24 and scMEC3 (the pre®xes here and after, h, sc, and sp refer to Homo sapiens, Saccaromyces cerevisiae, and Schizosaccharomyces pombe, respectively) are required for the DNA damage-induced G1 and G2 arrest and Sphase regulation Weinert et al., 1994; Paulovich and Hartwell, 1995; Paulovich et al., 1997) ; whereas, scPOL2, scRFC5, and scDBP11 are required for the S-phase arrest induced by DNA replication-blocking agents (Araki et al., 1995; Navas et al., 1995; Sugimoto et al., 1996) . Two kinases, scMec1/Esr1/Sad3 (Allen et al., 1994; Kato and Ogawa, 1994; Weinert et al., 1994; Sanchez et al., 1996) and scRad53/Spk1/Mec2/Sad1 (Stern et al., 1991; Allen et al., 1994; Weinert et al., 1994) appear to be transducers of the DNA damage signal, resulting in cell cycle arrest and transcriptional induction of repair genes (Elledge, 1996) . In the ®ssion yeast S. pombe, the`checkpoint-rad' group of genes including spRAD1, spRAD3, spRAD9, spRAD17, spRAD26, and spHUS1 is required for checkpoint arrest following both DNA lesions or replication blockage (AlKhodairy and Carr, 1992; Al-Khodairy et al., 1994; Carr, 1995) . The spChk1 and spCds1 kinases are required for survival upon DNA damage, or replication blockage with hydroxyurea (HU), respectively (Murakami and Okayama, 1995; Walworth and Bernards, 1996; Howard et al., 1998; Boddy et al., 1998) . spChk1 has been shown to act downstream of the`checkpoint rad' group as a signal transducer (Ford et al., 1994; Walworth and Bernards, 1996; Furnari et al., 1997) .
In mammals, ®ve genes, ATM, p53, p21/WAF1/ CIP1, hCHK1, and 14-3-3s have been identi®ed as components of DNA damage-induced checkpoint pathways. The Atm kinase, p53, and hChk1 are signal processing and transmitting factors (Yin et al., 1992; Savitsky et al., 1995; Sanchez et al., 1997) , while p21, and, possibly, 14-3-3s are eectors of checkpoint arrest (El-Deiry et al., 1993; Harper et al., 1993; Hermeking et al., 1997) . A member of the PI-3 kinase family, the ATM gene may actually function as a protein kinase (Hunter, 1995) . It has proven to be involved in G1/S, S, and G2/M DNA damage checkpoints, and is an element upstream of p53, since cells lacking ATM show a reduced activation of p53 in response to DNA damage (Kastan et al., 1992) . Upon DNA damage, the p53 cellular level, stability, and speci®c activity as a transcription factor are up-regulated (Lu and Lane, 1993; Levine, 1997) . One of the targets of p53 transactivation is the p21/CIP1/WAF1 gene, a downstream eector of the G1 checkpoint. p21 binds and inhibits a number of cyclin-dependent kinases, and mediates the arrest at the G1/S transition. In addition, it interacts with PCNA, thereby inhibiting DNA replication, and possibly eecting S phase arrest. The human Chk1 kinase is phosphorylated upon DNA damage, in a mechanism possibly mediated by Atm (Nurse, 1997), and phosphorylates Cdc25C on Ser216, resulting in a sequestration of Cdc25C phosphatase activity, which is necessary for the activation of Cdc2-cyclin B and mitotic entry. Thus far, signal transducing factors and the downstream eectors of the damage checkpoint have been partially elucidated in mammals. However, upstream elements which are responsible for detecting damage and originating checkpoint signals remain largely unknown.
Structural and functional conservation of the DNA damage checkpoint genes have been observed among budding yeast, ®ssion yeast, and mammals (Elledge 1996; Paulovich et al., 1997) , indicating that there is a common molecular mechanism underlying checkpoint controls throughout eukaryotic systems. In particular, signals derived from DNA damage are transmitted through conserved protein kinases common in all three organisms as re¯ected by the sequence conservation and functional similarity among scMec1, spRad3, Atm, and Atr. The Chk1 function and the involvement of the 14-3-3 proteins were also shown to be strictly conserved between ®ssion yeast and humans (Ford et al., 1994; Furnari et al., 1997; Peng et al., 1997; Sanchez et al., 1997) . Therefore, it is reasonable that certain upstream components which are responsible for detecting DNA damage and producing initial checkpoint signals, such as scRAD9, scRAD17, scRAD24 in S. Cerevisiae and spRAD1, spRAD9, and spRAD17 in S. pombe, may also exist and be required in mammalian DNA damage checkpoints. In fact, a human cDNA homologous to spRAD9 has been isolated and was found partially active in rescuing a sprad9 mutant phenotype (Lieberman et al., 1996) . To identify factors that are involved in the initial stages of mammalian checkpoint control, we have isolated, by a homology search, a human homolog of the spRAD17 gene, hRAD17. hRAD17 is also structurally homologous to scRAD24, which has been suggested to be involved in processing DNA damage and transducing the signal to downstream elements of S. cerevisiae checkpoint pathways Weinert, 1995, 1997) . We show here that the HU and IR sensitivity, but not the UV damage sensitivity, of S. pombe rad17 mutants can be partially complemented by hRAD17. When overexpressed in mammalian cells, hRad17 activates p53 and causes an accumulation of G1 phase cells, suggesting an involvement of the hRAD17 gene in cell-cycle checkpoint regulation.
Results

Identi®cation of the hRAD17 gene
The S. pombe RAD17 gene is a structural homolog of scRAD24. Both genes appear to function at initial steps of checkpoint control, and the scRad24 protein has been implicated in damage processing (Lydall and Weinert, 1995) . Loss of spRAD17 in S. pombe abrogates the G2 checkpoint and results in sensitivity to DNA damage and replication blocking reagents (Griths et al., 1995) . To identify a human homolog of spRad17, the full-length peptide sequence of spRad17 was used to conduct a BLAST search of the human EST database at Human Geonome Sciences, Inc. (HGS, Rockville, MD, USA). One EST sequence possessed a predicted 60 amino acid region with 29% identity and 56% similarity to spRad17. The complete nucleotide sequence of the 1.7 Kb EST insert was determined, and sequence alignment analysis revealed that the amino acid sequence from the largest open reading frame shared homology with the C-terminal half of spRad17 as well as scRad24. Therefore, a HeLa cDNA library was screened, using the EST sequence as a probe, to obtain a full-length cDNA. The longest cDNA clone obtained, after screening 400 000 colonies, contained a 2.8 Kb insert. Sequence analysis indicated that this cDNA insert is 2812 bp in length, has 268 bp of 5' untranslated region, an open reading frame of 2013 bp and 532 bp of 3' untranslated region. An inframe stop codon was found 30 bp upstream of the initiation codon. The open reading frame encodes a predicted polypeptide of 671 amino acids, which shares homology with both spRad17 and scRad24. When aligned in a pairwise fashion, hRad17 exhibits closer homology to spRad17, than to scRad24, with 28.3% identity and 52.7% similarity to the former protein, and 21.8% identity and 45.8% similarity to the latter.
Both the scRad24 and spRad17 proteins are known to exhibit signi®cant structural conservation with a family of proteins identi®ed as components of human RFC/activator 1, and with E. coli and bacteriophage T4 DNA polymerase accessory factors (O'Donnell et al., 1993; Griths et al., 1995) . The hRad17 protein also exhibits homology to these proteins (Figure 1 ). RFC is a multifactorial complex composed of ®ve subunits and functions as a loading factor for PCNA during DNA polymerases d and e-mediated DNA synthesis (Pan et al., 1993) . Among the ®ve proteins, including scRad24, sprad17, and hRad17, and the 36 kd and 37 kd subunits of RFC, the homology is distributed, most prominently, through four domains within the N-terminal portion, including a nucleotide binding motif. When aligned in a pairwise fashion, the overall similarity between hRad17 and subunits of the RFC/activator 1 falls below 20% with even lower percentage of identity, indicating that hRad17 is much more closely related to the ScRad24/SpRad17 than to the RFC/activator 1 subunits.
The hRAD17 gene is ubiquitously expressed A Northern blot analysis was performed to determine the expression pattern of the hRAD17 gene (Figure 2 ). The size of the hRAD17 transcript appears to be approximately 2.8 Kb, indicating that the hRAD17 cDNA clone that we have isolated is near full-length. The experiment also showed that the hRAD17 gene is transcribed in all eight human tissues examined, although, the observed expression is relatively lower in placenta, lung, and liver ( Figure 2a , lanes 3, 4 and 5), and high in cardiac and skeleton muscle ( Figure 2a , lanes 1 and 6). A search of the NCBI dbest data base also found multiple human ESTs in testis, colon, retina and uterus, suggesting hRAD17 is ubiquitously expressed. Furthermore, we have isolated a mouse cDNA with 76% homology to hRad17 at the amino acid level, which most likely represents its mouse homolog (unpublished data). The apparent ubiquitous expression pattern of the hRAD17 gene is consistent with a role in cell cycle checkpoint regulation. Hydroxyurea and ionizing radiation sensitivity of the S. pombe rad17 mutant can be partially complemented by hRAD17
The hRAD17 full-length cDNA, tagged with the hemagglutinin (HA) epitope, was cloned into the S. pombe expression vector pREP1 (Maundrell, 1990) , under control of the inducible nmt1 promoter, and transformed into the S. pombe rad17.w checkpoint mutant, and a wild type strain to examine its ability to rescue the HU and UV sensitivity of the mutant. Induction of hRAD17 expression was con®rmed by Western blot analysis with an anti-HA antibody ( Figure 3a) . Transient exposure to HU greatly reduced the survival of the rad17 mutant cells transformed with the pREP1 vector alone. (Figure 3b ). In comparison, the rad17 mutants cells transformed with the pREP1-hRAD17 construct exhibited a moderate, but distinct, increase in viability. In contrast, expression of hRAD17 had a minimal negative eect on cell survival in wild type cells. Also, overexpression of hRAD17 in wild type and rad17 mutant cells had no eect on cell growth as measured by doubling times, indicating that the decrease in sensitivity to Hu is not due to a slower growth rate. Similarly, the hRAD17 gene was able to partially complement the radiation sensitivity of the S. pombe rad17.w mutant to a comparable degree ( Figure  3c ). We also examined hRAD17 for its ability to complement the UV sensitivity of the rad17 mutant, however, no signi®cant complementation was observed (data not shown).
Overexpression of hRAD17 in human ®brosarcoma cells leads to G1 accumulation
In order to examine whether hRAD17 is involved in mammalian checkpoint pathways, we established a human cell population overexpressing hRAD17, and examined its cell cycle status. The full-length hRAD17 gene was cloned into a mammalian episomal expression vector, pEBS7 (Peterson and Legerski, 1991) . The resulting construct, pEBS7-hRAD17, was transfected into HT-1080 human ®brosarcoma cells and selected with hygromycin B. Cell transformants were pooled together to form a hRAD17 overexpressing population. A control cell population transformed with the pEBS7 vector was also established in parallel. Total RNA was isolated from both cell populations and RT ± PCR was performed to examine overexpression of the hRAD17 gene. An upstream primer, EBS7 ± CAP, is located immediately downstream of the CAP site of the CMV promoter region in the pEBS7 vector, and a downstream primer, hRAD17 ± OE, is located within the 5' region in the hRAD17 coding sequence. When used together, this primer pair ampli®es exclusively the hRAD17 transcripts derived from the pEBS7-hRAD17 construct. (Figure 4a, top) . The total amount of hRAD17 mRNA was assessed by RT ± PCR with the primer pair, G1 ± G4, which ampli®es the 3' untranslated region of the hRAD17 message. From the results shown in Figure 4a , (middle panel), the level of hRAD17 message in the overexpressing cells is over twofold compared with that of the control cells. An internal control for the RT ± PCR, with primers speci®c to the Cockayne's syndrome group A gene, is shown in Figure 4a (bottom panel), and indicates that equal amounts of RNA template were used in these ampli®cations.
Having con®rmed the overexpression status of the hRAD17 gene in the HT-1080 cell line, we used FACscan to analyse the cycling status of the overexpressing and control cells. Asynchronously proliferating cells were allowed to grow to midexponential phase, and the cell cycle distribution of the hRAD17 overexpressing and the control cells was determined by FACS analysis using propidium iodide staining. As shown (Figure 4b ), cells overexpressing hRAD17 have a cell cycle distribution of 46.7+3.6% G1 phase, 30.0+2.3% S-phase, and 24.5+1.4% G2/ M-phase cells. In contrast, the control levels have 33.9+1.0% G1, 41.9+2.2% S, and 24.1+1.3% G2/ M-phase cells. Therefore, overexpression of hRAD17 has resulted in a signi®cant accumulation of the G1 population accompanied by a reduction of S-and G2/ M-phase cells, suggesting that hRAD17 may have a role in a cell cycle checkpoint that possibly leads to a G1 restriction. We have obtained similar results with bivariate FACscan analysis of the control and hRAD17 overexpressing cells pulse-labeled with BrdU (data not shown).
p53 can be activated by hRAD17 overexpression
Based on the models established in S. cerevisiae and S. pombe, scRad24/spRad17 function upstream of the signal transduction elements scMec1/spRad3 to generate an initial checkpoint signal (Weinert et al., 1994; Bentley et al., 1996) . Therefore, it is conceivable that hRad17 may activate Atm, and/or p53 in mammalian cells. We examined the induction of p53 upon hRAD17 overexpression, since p53 is upregulated after DNA damage (Levine, 1997) . Western blot analysis was performed to determine the cellular levels of p53 in cells that overexpress hRAD17 (pooled pEBS7-hRAD17 transformants), and control cells (transformed with pEBS7 vector alone). A 3 ± 4-fold increase (Figure 5a ), indicating that hRad17, when overproduced, was able to induce p53 accumulation. The functional status of p53 in the HT-1080 cell line has been veri®ed by Western blot analysis and showed that both p53 and p21 CIP1 were induced by ionizing radiation. To directly visualize the increased p53 level resulting from hRAD17 overexpression, transient transfections of pEBS7-hRAD17 were carried out with HT-1080 cells. Immunostaining was used to determine the activation of the p53 protein as signi®ed by increased nuclear accumulation (Lu and Lane, 1993) . Transfection of pEBS7-hRAD17 into HT-1080 cells led to elevated p53 nuclear staining (Figure 5c , upper left), similar to that observed with cells transfected with the p53 expression construct, pC53NN (Kern et al., 1992) (Figure 5c, upper right) . To verify the expression of hRAD17 in transiently transfected cells, a second pombe wild type and mutant strains transformed with either pREP1-hRAD17 or pREP1 only, when treated with IR. Both survival curves represents the average of three independent experiments. Error bars in HU and IR survival curves were generated from four readings per data point and three independent experiments, respectively eukaryotic expression vector, pcDNA3.1 was used to express HA-tagged hRad17 in HT-1080 cells. Western analysis with an anti-HA monoclonal antibody con®rmed the expression of HA-tagged hRad17 (Figure 5b ). This construct also showed induction of p53, when stained with anti-p53 antibody (Figure 5c , lower right). In addition, somatic cell microinjection was used to introduce the pEBS7-hRAD17 construct into primary human ®broblast WI ± 38 cells. In these cells, hRAD17 expression was also able to activate p53 as assayed by immunostaining (data not shown). One possible explanation for these results and the data derived from FACS analysis is that ectopic expression of hRad17 may stimulate a checkpoint signal that leads to p53 accumulation and G1 restriction.
The hRAD17 gene locus is assigned to human chromosome 5q11.2 PCR primers were designed to amplify an intronless fragment in the 3' untranslated region of the hRAD17 gene. These primers were able to speci®cally amplify the predicted 384-bp fragment from human HT-1080 genomic DNA, and exhibited no background with Chinese hamster ovary (CHO) genomic DNA. An initial chromosomal assignment was carried out by PCR ampli®cation of a 17-member human-CHO cell hybrid clone panel that was informative for every human chromosome (Stallings et al., 1988) . PCR products were obtained from 6 cell lines of the hybrid panel and segregated concordantly with markers for human chromosome 5 around the 5q11 ± 13 region (results not shown). To further con®rm this assignment, genomic DNA from a 22-member human-CHO mono-chromosome hybrid cell panel was examined for the 384-bp hRAD17-speci®c fragment. As shown (Figure 6 ), only the hybrid cell clone containing human chromosome 5 yielded the 348 base pair hRAD17-speci®c PCR product. These results indicated that the hRAD17 gene is located on human chromosome 5.
To achieve the regional assignment of the hRAD17 locus, a Mega-YAC library was screened by PCR ampli®cation with primers used in PCR mapping. Five YAC clones were obtained, and three were shown to contain the hRAD17 genomic sequence as determined by Southern blot analysis with full-length hRAD17 as probe. Inter-Alu-PCR products from one YAC clone, Y920C9, were generated and used as probe in two independent FISH experiments. One-color competitive FISH was used to eliminate chimeric YACs and to visualize the hybridization signal, which appeared to be on the long arm side of the centromere of chromosome 5 (Figure 7a ). Two-color FISH was performed to paint and R-band chromosome 5 (Figure 7b,b' ). Ten metaphase spreads were examined and all showed an identical pattern of hybridization at band 11.2 of the 5q arm. We therefore conclude that the hRAD17 gene is located at 5q11.2.
Discussion
Increasing evidence suggests that DNA damage checkpoint pathways may be conserved throughout eukaryotes. Recent studies have established a DNA damage checkpoint model with combined observations from yeast and human studies (Elledge, 1996; Weinert, 1997) . In both ®ssion and budding yeast, a group of upstream checkpoint factors, such as scRad17 and scRad24 in S. cerevisiae and spRad1 and spRad17 in S. pombe, are required for detection of DNA damage and disrupted replication, and initiation and transduction of the checkpoint signal to downstream kinases (scMec1 and spRad3). In mammals, however, this portion of the damage checkpoint pathway is largely unknown, although there is evidence to suggest that p53 and Atm interact with DNA damage directly or indirectly through association with other proteins (Lee et al., 1995; Plug et al., 1997) . The aim of our study was to identify mammalian upstream factors that are responsible for sensing aberrant DNA structures and originating checkpoint signals.
In the ®ssion yeast S. pombe, the RAD17 gene is one of the six`checkpoint rads' which are essential to DNA damage/replication block checkpoint functions (AlKhodairy and Carr, 1992) . The rad17 null mutant is viable, but is defective in DNA damage-induced G2 arrest, and is defective in the dependency of mitosis upon completion of S-phase. Previously, spRad17 has been identi®ed as a structural homolog of the budding yeast scRad24 protein (Griths et al., 1995) . Through a sequence homology search, we have isolated a human sequence homolog of spRAD17, hRAD17, which revealed a further structural conservation of checkpoint components between human and yeast. In addition, the structural conservation previously identi®ed between Rad17 homologs and the RFC/replication accessory factor family was con®rmed in the sequence of hRad17. This structural homology, however, does not necessarily suggest a functional conservation between the two group of proteins. In budding yeast, RFC is absolutely required for DNA replication (McAlear et al., 1996) , and is, therefore, essential to viability, whilst both scRAD24 and spRAD17 are nonessential genes in the absence of DNA damage or replication blockage. Rather, the sequence similarity with RFC subunits may provide clues toward the possible biochemical nature of the mechanism of Rad17 function. The Rad17 protein may be involved in a DNA-binding activity since the RFC complex in conjunction with PCNA binds to template-primer junctions in replicating DNA (Pan et al., 1993) , or, hRad17 protein could potentially regulate DNA synthesis by interacting with elements of the replication machinery upon induction of a checkpoint signal (Lydall and Weinert, 1997) .
When introduced into a sprad17 mutant, hRAD17 was able to partially correct the HU and gamma radiation, but not the UV hypersensitivity of this strain. This result, on one hand, supports a possible function conservation between the two proteins, while on the other hand, its re¯ects a loss of conservation in particular aspects of the detailed mechanisms of cell cycle checkpoints in these dierent systems. In spite of the close structural homology between the two yeast genes, scRAD24 was unable to correct the phenotype of a sprad17 null mutant (Griths et al., 1995) . In correspondence with our results, the human homologs of spRAD1 (Marathi et al., submitted elsewhere) and spRAD9 (Lieberman et al., 1996) were shown to partially complement the HU and ionizing radiation hypersensitivity of sprad1 and sprad9 mutants, respectively, but nonetheless failed to rescue the UV sensitivity. Using a stable transfection approach, we overexpressed hRAD17 in HT-1080 cells and found bȳ ow cytometry analysis that ectopic expression signi®cantly increased the G1-phase population, suggesting a possible G1 restriction in the absence of DNA damage or replication blockage. Similar observations have been made upon the overexpression of other checkpoint genes. For example, the spCHK1 gene overexpressed in S. pombe resulted in a G2 arrest that stimulates the eects of DNA damage or replication blockage (Ford et al., 1994) , and scRAD24 overexpression in a budding yeast mutant, with a DNA replication defect, strongly reduced the growth rate (Lydall and Weinert, 1997). In mammalian systems, overexpression of wild-type p53 arrests cells in late G1, prior to the restriction point (Diller et al., 1990) . A high cellular level of a checkpoint protein may exaggerate its basal activity, and thus, mimic the presumed activation by DNA damage or replication blockage. An approach to verify this hypothesis is to measure the activation of possible downstream elements of the checkpoint pathway. Models established in both budding yeast and ®ssion yeast indicate that the scRAD24/spRAD17 gene function is upstream of the scMec1/spRad3 kinase (Bentley et al., 1996) . If similar mechanisms are conserved in mammals, hRad17 function would be placed upstream of Atm, and also p53, since its induction has been shown to be dependent upon Atm (Kastan et al., 1992) . Consistent with this model are our ®ndings that p53 levels are elevated in hRAD17 permanently transfected HT-1080 cells, and induction of p53 is observed in both HT-1080 and primary human ®broblast cells transiently transfected with hRAD17. These results are consistent with a model in which hRAD17 is involved in the origination of checkpoint signals.
Under normal growth conditions, cells with deletions or mutations in certain checkpoint genes do not usually exhibit altered phenotypes; however, after induction of DNA damage, checkpoint pathways are found to be abrogated resulting in increased genomic instability (Hartwell and Kastan, 1994) . The ®nding that both p53 and ATM are commonly mutated in a wide variety of human cancers suggests that abnormalities in checkpoint controls are important to tumorigenesis. Using PCR mapping and FISH analysis, we have assigned the hRAD17 locus to human chromosome 5q11.2. Interestingly, the q-arm of chromosome 5 is a frequently altered region in a variety of human tumors, including small-cell lung and ovarian cancer, esophageal carcinoma, and acute myeloid leukemia (Barrett et al., 1996; Miura et al., 1992; Shibagaki et al., 1994) . Because of its likely role in checkpoint controls, we are examining the possibility that hRAD17 may be a tumor suppressor at the 5q11.2 34 Figure 6 Chromosomal mapping of the hRAD17 gene. PCR analysis using total human (HT-1080) or hamster (CHO) DNA, or DNA isolated from somatic cell hybrids containing a single human chromosome as indicated. M, Kb DNA marker Figure 7 FISH mapping of hRAD17 locus. (a) FISH analysis of human chromosomes using hRAD17 inter-Alu-PCR probe that has been biotinylated and detected with avidin-¯uorescein. The metaphase is of a tetraploid cell and four speci®c pairs of hybridization signals are found on four chromosomes that appear to be chromosomes 5. (b) Panel b and b' are from the same section of a human metaphase spread on which two-color FISH has been conducted. In b, the red signal was produced by the digoxygenin-labeled hRAD17 probe. In b', the green signal was generated by biotin-labeled inter-Alu PCR probe derived from human chromosome 5. The arrows mark the positions of the centromeres. The inter-Alu-PCR chromosome 5 probe paints and R-bands the chromosome, identifying the hRAD17 hybridization signal as located just below the centromere (arrow) in band q11.2 locus. While this paper was in revision, Parker et al. (1998) reported on the cloning and characterization of a hRAD17 homolog that is nearly identical (a discrepancy of three amino acids) to the gene that we have reported here. However, their mapping results indicate that hRAD17 is localized to human chromosome 4q13.3-21.2. The reason for this discrepancy is unclear, however, as indicated above we have mapped hRAD17 by three independent methods and the results of all three experimental approaches indicate that hRAD17 resides at the chromosome 5q11.2 locus.
Materials and methods
Cell lines and strains
The following S. pombe strains were used: GK1 (h+leu1-32 ura4-D18; wild type); GK3 (rad17-W his3 leu1 ura4) (Dahlkvist et al., 1995) . S. pombe cells were grown in EMM medium (Moreno et al., 1991) at 308C. Transformation was performed with a lithium-acetate protocol. HT-1080 human ®brosarcoma and WI ± 38 fetal lung ®broblast cells were obtained from the American Type Culture Collection and cultured in MEM media with 10% fetal calf serum (FCS) (Sigma). Transfection of mammalian expression constructs into HT-1080 cells was performed by the method of calcium phosphate coprecipitation. After transfection, cells were selected and maintained in 10% FCS ± MEM supplemented with 75 mg/ml of hygromycin B.
DNA cloning and sequencing
The DNA sequence of both strands of hRAD17 cDNA was determined using the ABI-PRISM model 377 automated sequencer (Perkin Elmer, Foster City, CA, USA). The dideoxy termination reaction using double-stranded DNA as template was performed with a Fluorescent Dye Terminator Kit (Perkin Elmer, Foster City, CA, USA). Oligonucleotides used in DNA sequencing and PCR were designed with the Oligo Primer Analysis Program (National Biosciences, Inc., Plymouth, MN, USA). To construct the mammalian expression vector that expresses the hRAD17 gene, the full-length hRAD17 cDNA was directionally cloned into the S®I and NotI sites of the pEBS7 vector (Peterson and Legerski, 1991) . pcDNA3.1 (Invitrogene Inc., Carlsbad, CA, USA) was used to express an HA-tagged hRAD17 cDNA in transient transfection experiments. Pairwise sequence comparison of peptide sequences was performed with the BESTFIT program from the GCG package (Genetics Computing Group, Madison, WI, USA). Multiple peptide sequence alignment was carried out with the ClustalW program using the PM250 weighing matrix. Other sequence analyses were carried out with the Lasergene Navigator package (DNASTAR Inc., Madison, WI, USA).
Northern analysis and RT ± PCR
Pre-blotted nylon membranes with human poly(A) + RNA from multiple tissues were purchased from Clontech. Northern hybridization with random primed hRAD17 cDNA and human b actin probes was carried out in Hybrisol I buer (Oncor, Gaithersburg, MD, USA) according to manufacturer's speci®cations. For RT ± PCR experiments, total RNA was isolated from 5610 6 cells and 0.5 mg of each total RNA was used in the ®rst-strand cDNA synthesis reaction. Reverse transcription was primed with oligo(dT)20 and carried out with SuperScript II reverse transcriptase (Gibco-BRL, Gaithersburg, MD, USA) according to the manufacturer's speci®cations. PCR reactions were limited to the linear ampli®cation range, and all reactions were performed under identical conditions. PCR was carried out on a GeneAmp Biosystem 9600 (Perkin Elmer, Foster City, CA, USA) in a 50 ml volume using 0.5 ml of each ®rst strand synthesis reaction as template. The PCR cycling conditions were: 30 s at 948C, 1 min at 558C, and 2 min at 728 for 25 cycles, with a 5 min preincubation at 948C, and a ®nal extension of 30 min at 728C. The oligonucleotides used in the quantitation of hRAD17 transcripts were: EBS7-CAP, 5' GGAGACCCAAGCTTCTAGAGAT 3'; hRAD17-OE, 5' CCATGGTTCATTTTCAGACAGA 3'; G1, 5' TTCACAGCTTCATTTTTGTT 3'; G4, 5' GCGGGAGACAATAAAGTGTA 3'; CSA-M1, 5' GCCGGTGTGAGGACACGATA 3'; CSA-M2, 5' AGCACTTGCTGTTGCCAAGA 3'.
Hydroxyurea (HU) and ionizing radiation (IR) sensitivity assay S. pombe cells transformed with either empty pREP1 (Maundrell, 1990) vector or pREP1-hRAD17 were selected on EMM (Moreno et al., 1991) plates supplemented with 2 mM thiamine to suppress expression from the nmt1 promoter. A pool of transformants was expanded in liquid selective medium plus thiamine. Care was taken that all cultures to be included in the experiment were at the same density, and were at no time allowed to reach stationary phase. At 18 h before application of HU, cells were washed free of thiamine, again adjusted to the same density, and were grow in thiamine-free EMM. When the cell density was 5610 6 ml, HU was added to a ®nal concentration of 10 mM to one half of the cultures. Aliquots were removed at various times thereafter. Cells were washed free of HU and plated on thiamine-free EMM at appropriate dilutions. For gamma irradiation, a 137-Cs source with a dose rate of 0.5 krad/min was used. Cells were mock-irradiated for the time required to make up for the dierence between the actual and the maximal dose. After plating on thiamine-free EMM at appropriate dilutions. Survival was recorded by colony-counting after three days of growth.
Flow cytometry analysis
5610
5 exponentially proliferating cells were collected by trypsin/EDTA treatment, washed once with ice-cold PBS, ®xed by drop-wise addition of absolute ethanol pre-chilled at 7208C, and stored on ice overnight. Fixed cells were then pelleted, resuspended in 0.005% pepsin and 0.1 N HCl, and incubated at 378C for 45 min. The pelleted nuclei were then resuspended in 2N Hcl, incubated for 45 min at room temperature, and neutralized by washing in 0.1 M sodium borate. The nuclei pellets were resuspended in PBS containing 10 mg/ml of propidium iodide, and stored at 48C for at least 6 h before analysing. Two-color fluorescence analysis was performed on a FACscan (Becton Dickinson) system, and the¯ow data were processed with the LYSIS II and CellFIT programs with proper gating to exclude conjugated cells. For bivariate¯ow cytometry studies, cells were pulsed labeled for 20 min with 10 mM BrdU prior to harvesting. The samples were processed as above and stained, after denaturation of the DNA, with uorescence isothiocyanate-conjugated anti-BrdU antibody (Becton Dickinson, Franklin Lakes, NJ, USA) according to the manufacturer's instructions.
Immunostaining analysis Cells growing on cover slips were ®xed, 32 h after transfection or 24 h after microinjection, with acetone pre-chilled at 7208C. PBS solution contain-ing 3% BSA and 5% goat serum was used to block the samples for 20 min at room temperature. The samples were then incubated with anti-p53 antibody (MoAb421, a kind gift from Dr Gigi Lozano, Department of Molecular Genetics, UTMDACC) at 378C for 1 h. FITC-conjugated goat anti-mouse antibody (Jackson Immunoresearch Laboratories, West Grove, PA, USA) was used as secondary antibody. Anti-HA monoclonal antibody was kindly provided by Dr Bing Su (Department of Immunology, UTMDACC). Immunoblotting result was quanti®ed with the ImageQuant analysis software from Molecular Dynamics (Sunnyvale, CA, USA).
Chromosomal mapping and regional assignment with FISH Human-CHO somatic cell hybrids were embedded in agarose plugs, and digested with proteinase K to prepare embedded chromosomal DNA. The plugs were melted at 758C for 30 min, and approximately 50 ng of each of the hybrid DNA samples was used in PCR ampli®cation with Taq polymerase (Promega, Madison, WI, USA) following instructions by the manufacturer. Custom YAC library screening service was provided by the Human Genome Center at Baylor College of Medicine. The CEPH MEGA-YAC library was screened by PCR with primers G1 and G4. DNA speci®c to human chromosome 5 was produced by inter-Alu-PCR from a somatic cell hybrid monochromosomal for human chromosome 5 (GM10115 obtained from the Coriell Institute, Camden, NJ, USA) and used as a probe for¯uorescent in situ hybridization (FISH). Probe DNA for YAC 920C9 was also produced by inter-Alu-PCR. FISH was conducted on metaphase preparations from normal human lymphoblastoid cells using standardized methodology. Probes were labeled with either biotin or digoxigenin. Biotin-labeled probes were visualized using FITC-avidin and anti-avidin antibody from Oncor. Digoxigenin labeled probes were detected with rhodamine tagged anti-digoxigenin antibody (Oncor, Gaithersburg, MD, USA) and rabbit anti-sheep antibody as required for ampli®cation as per manufacturer's instructions. Slides were counterstained with propidium iodide/antifade or DAPI/antifade and examined with an OLYMPUS fluorescent microscope equipped with red-pass and green-pass ®lters.
